Poor Dissociation of Patient-Evaluated Apathy and Depressive Symptoms by Progress Njomboro & Shoumitro Deb
Hindawi Publishing Corporation
Current Gerontology and Geriatrics Research
Volume 2012, Article ID 846075, 8 pages
doi:10.1155/2012/846075
Research Article
Poor Dissociation of Patient-Evaluated Apathy and
DepressiveSymptoms
Progress Njomboro1 andShoumitroDeb2
1Department of Psychology, University of Cape Town, Private Bag Rondebosch, Cape Town 7701, South Africa
2Department of Psychiatry, Division of Neuroscience, University of Birmingham, Birmingham B15 2TT, UK
Correspondence should be addressed to Progress Njomboro, progress.njomboro@uct.ac.za
Received 16 January 2012; Revised 21 March 2012; Accepted 27 March 2012
Academic Editor: Iracema Leroi
Copyright © 2012 P. Njomboro and S. Deb. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Apathy has traditionally been conceptualised as part of depression. The appropriateness of this conceptualisation has now been
questioned, with the realization that apathy constitutes a distinct neuropsychiatric condition, with separate rehabilitation and
patient-careimplicationstodepression.Researchontherelationshipbetweenapathyanddepressionhas,however,producedmixed
results. One reason for this inconsistency may lie behind who does the apathy evaluation. In this study we investigated whether the
relationship between apathy and depression would diﬀer when apathy was evaluated by the patients or an informant. A total of 49
brain damaged patients were assessed on self- and informant-rated Apathy Evaluation Scales. The relationship between the apathy
scores and depressive symptoms was then investigated. Patient-rated, and not informant-rated apathy signiﬁcantly correlated with
depression. We discuss the implication of these results on the relationship between the two neuropsychiatric conditions and also
in relation to the utility of patient self-evaluations in apathy.
1.Introduction
The position of apathy as a distinct syndrome in both
clinical practice and research is still uncertain and less clearly
deﬁned. Generally, apathy is conceptualised as constituting
a signiﬁcant loss of motivation [1]. For diagnostic purposes,
this loss of motivation must be present for at least four weeks
and should manifest in at least two of three dimensions of
apathy involving reduced overt acts, cognitive activity, and
aﬀective responses related to goal directed behaviour [2].
The clinical importance of apathy is demonstrated through
its association with reduced patient independence, social
integration, rehabilitation success, and increased caregiver
burden [3] and its high prevalence in patients suﬀering
neurological change [4]. For instance, incidence of between
17–70% has been reported in Parkinson’s disease [5, 6],
and incidence of between 46 and 71% has been reported
in patients with traumatic brain injury [7, 8]. Similar high
incidence rates have been reported in Alzheimer’s disease,
frontotemporal dementia, progressive supranuclear palsy,
and stroke [9–11]. See also [12]f o rar e v i e w .
Much of the debate on apathy in the past decade has
focused on its nosological position, particularly its relation
to depressive symptoms [6, 13–16]. Traditionally, apathy has
been viewed as a symptom of depression. Clinically, the two
disorders are related in that they signiﬁcantly overlap on
symptom dimensions related to loss of interest, anhedonia,
and reduced activity [9, 17]. This debate on the relationship
between apathy and depression still remains important.
For instance, the inclusion of a dimension of “diminished
interest” as a core symptom of depressive disorder is now
queried, with some suggesting that this symptom dimension
relates more to apathy than depression [5]. Also worryingly,
one study found that, in 33% of Parkinson’s disease patients
suﬀering from minor depression and 8% suﬀering from
major depression, this diagnosis was made solely on the
basis of loss of interest in the absence of depressed mood
[18]. Evidence also suggests that quite often apathetic
patients are misdiagnosed as depressed by practitioners, and
consequently wrongly prescribed antidepressants [19].
Some of the distinctions between apathy and depression
are now widely appreciated. For example, while depression2 Current Gerontology and Geriatrics Research
is a mood disorder involving emotional pain, negative cog-
nitive biases, despair, hopelessness, and pessimism, apathy is
primarily a disorder of motivation, marked by general lack
of interest, concern, or care about almost anything [9, 20].
Furthermore,apathyandnot depressionis usuallyassociated
with cognitive impairments, which indicate separate neu-
rocognitiveproﬁlesforthetwoconditions[16,21–24].There
is also evidence that separate brain circuits are involved in
apathy and depression [25, 26], further strengthening the
view that the two are diﬀerent neuropsychiatric disorders.
Despite these noted diﬀerences, some studies have reported
signiﬁcant symptom overlap between the two syndromes
[15] or shown a signiﬁcant association between depression
and apathy symptoms [24]. In one study on Parkinson’s
patients [27], apathy coexisted with depression in 43%
of the patients. Other studies have found a modest or
low correlation between the two disorders [16, 28]. For
alternative results, see [29].
A number of possible explanations, ranging from the
use of diﬀerent assessment tools and clinical samples across
studies; frequency of both apathy and depression in patients
with neurological damage (e.g., [27, 30, 31]); the use of
diﬀerent cutoﬀs on apathy scales (see [10, 32, 33]), may
account for the variations in the reported relationships
between apathy and depression. Some depression scales also
treat apathy as a symptom of depression [28, 34]. For
example,theHAMD-21hasanitemon“Workandactivities”
that speciﬁcally target apathy [35]. Moreover, the concepts of
apathy and depression both share the predicate of “reduced
volition,” which implies some phenomenological overlap
between the two [9, 19, 32].
The use of patient or informant rated apathy scores
across diﬀerent studies may also account for the mixed
ﬁndings on the relationship between apathy and depression.
Evidence suggests that brain-damaged patients are poor at
self-evaluating their apathy symptoms [36]. So far, no study
hasinvestigatedhowusingpatientorinformant-ratedapathy
scoresmediatestherelationshipthatisfoundbetweenapathy
and depression. This factor is crucial in light of the overlap
between apathy symptoms, cognitive deﬁcits, and lack of
insight commonly seen in patients suﬀering neurological
change [5, 6, 37]. It is possible diﬀerential apathy ratings
between patients and informants account for part of the
inconsistent research results in this area.
This study focuses on the relationship between apathy
and depression in patients with acquired brain damage.
Speciﬁcally, we investigated whether this relationship is
mediated by the use of patient or informant-rated apathy
scores. The self (AES-S) and informant-rated (AES-I) ver-
sions of the Apathy Evaluation Scale (AES; [10]) and the
apathy section of the Neuropsychiatric Inventory (NPI; [38])
were used to assess apathy. Correlations with an apathy score
ontheNPIwereusedtoenabletheindependentexamination
of the relationships between the two AES versions. The
NPI and AES are the most widely used and psychome-
trically robust scales for assessing apathy (see review by
[39]). We hypothesised that patient and informant-rated
apathy would relate diﬀerently to depression. The level
of depressive symptoms was evaluated using the Hospital
Table 1: Patient characteristics and cause of brain injury.
Etiology N
Sex
M = male
F = female
Age
Mean and
(St. Dev)
Cerebrovascular
accident 24 M = 15; F = 9 54.44 (9.73)
Head injury 14 M = 11; F = 3 48.25 (15.27)
Anoxia 5 M = 5; F = 0 49.80 (11.05)
Herpes simplex
encephalitis 6M = 5; F = 1 42.50 (8.60)
Total 49 M = 36; F = 13 50.89 (13.94)
Anxiety and Depression Scale (HADS-D; [40]) and the
Depression Inventory (BDI; [41]). Most studies investigating
the relationship between apathy and depression have tended
to use homogenous patient samples (e.g., [5, 6, 32]). The
weakness in such studies is that the relationship between
apathy and depression may interact in some speciﬁc ways
with the aetiological process. For that reason, our aim
was to take brain-damaged patients from a wide range of
aetiologies, in order to give a broad sample of possible
relations between depression and apathy. We also obtained
an executive function measure on the Tower of Hanoi task
(ToH), to assess patients’ cognitive control.
2. Methods
2.1. Participants
2.1.1. Patients. A total of 49 brain-damaged patients at least
6 months after-injury took part in the study (see Table 1
for patient characteristics). Patients were recruited from
clinics and rehabilitation centres in the West Midlands,
United Kingdom. Informed written consent was obtained
from all participants. Lesion data was available on 46
patients.In25patients,thelesionsweredetectedusingvoxel-
based morphological analysis in SPM5 (http://www.ﬁl.ion
.ucl.ac.uk/spm/software/spm5). The images were ﬁrst seg-
mented into grey matter, white matter, and cerebrospinal
ﬂuid (CSF), and the resulting tissue classes images were
normalized without modulation (i.e., to compensate for the
eﬀect of spatial normalization). Images were smoothed with
a Gaussian kernel of 2 × 2 × 2mm. Signiﬁcant changes
were based on one sample t-tests with 3 covariates: healthy
grey/white matter versus patient grey/white matter, age, and
gender. All areas were FWE corrected with P = 0.05 and
an extent threshold specifying that only signiﬁcant blobs
containing ≥100 voxels be included in the lesion. In the
other 21 patients, data on lesion location was obtained from
reports in patient ﬁles on scans performed before admission
to rehabilitation units. Twenty-two patients had bilateral
frontotemporal lesions, 7 had right fronto-temporal lesions,
7 had left frontotemporal lesions 1 had bilateral parietal
lesions, 4 had right parietal lesions, and 5 had left parietal
lesions.Current Gerontology and Geriatrics Research 3
2.1.2. Informants. Patients’ caregivers gave evaluations on
the AES-I and the NPI. These informants were either
relatives, or care-workers (in the case of patients in reha-
bilitation units) that interacted with the patient on a daily
basis, and in all the cases, had known the patients for
at least 5 months. On both instruments, the principal
investigator sat with the informants and read out each of the
items, seeking clariﬁcation on responses that were not clear.
The Birmingham and Solihull Research Ethics Committee
approved the research procedures for this project, and all
participants gave informed written consent.
2.2. Apathy Evaluation. Patients were evaluated for levels of
apathy using the self (AES-S) and informant- (AES-I) rated
versions of the Apathy Evaluation Scale [10] and also on the
apathy section of the Neuropsychiatry Inventory (NPI [38]).
2.2.1. The Apathy Evaluation Scale [10]. The AES is an 18-
itemscalethatassessesbehavioural,emotional,andcognitive
aspects of apathy. Each item (e.g., s/he gets things done during
t h ed a y / Ig e tt h i n g sd o n ed u r i n gt h ed a y )is rated on a scale
of 1 (Not at all) to 4 (A lot). A higher AES score indicates
more apathy. The scale has been widely used for research and
showntodemonstrategoodpsychometricproperties[10,42,
43].WeusedanAEScut-oﬀscoreof38(AES-S)and40(AES-
I) to determine whether patients were apathetic on not [10].
2.2.2. The Neuropsychiatric Inventory [38]. The neuropsy-
chiatric inventory (NPI) evaluates 10 speciﬁc behavioural
domains; delusions, hallucinations, agitation, depression,
anxiety, elation, apathy, disinhibition, irritability, and aber-
rant motor behaviour and gives a subscore for each of these
domains. If a speciﬁc neuropsychiatric symptom is present,
it is rated on a 4-point frequency scale (occasionally = 1;
often = 2; frequently = 3; very Frequently = 4) and a separate
3-point severity scale (mild = 1, moderate = 2, marked =
3). Multiplying the frequency rating score by the severity
rating score produces the subscale score for each behavioural
domain. For purposes of this study, only the apathy subscale
was used. It includes items such as showing loss of interest,
lacking motivation, less spontaneous, less aﬀectionate, less
enthusiastic,lackinginemotions,andnotcaringaboutdoing
new things. The subscale has demonstrated good internal
consistency (α = .87–.88), test-retest (r = .74 for
frequency), and interrater reliabilities (r = .89 for severity
and r = .98 for frequency [38]. The subscale has also been
used to assess apathy in a number of studies (e.g., [33, 44]).
We took NPI scores above 4 as indicative of the presence of
apathy [45].
2.3. Depressive Symptoms Evaluation. The presence and level
of depressive symptoms were evaluated using [40]’s Hospital
Anxiety and Depression Scale (HADS-D) and the Beck
Depression Inventory (BDI).
2.3.1. Beck Depression Inventory [41]. The BDI has enjoyed
wide usage as a valid and reliable assessment tool for
depressive symptoms [46]. Patients evaluate themselves by
putting a circle on one of the 4 likert-type statements making
each of the 21 items making up the inventory. Scores on each
statementrangefrom0(absenceofthataspectofdepression)
to 3 (most severe). For example, “I do not feel sad” carries
as c o r eo f0 ,“I feel sad” as c o r eo f1 ,“l am sad most of the
time and l cannot snap out of it” as c o r eo f2 ,a n d“ Ia ms o
sad or unhappy that l cannot stand it,” as c o r eo f3 .T h eB D I
scoreisobtainedbysummingupallthescores.Ahigherscore
suggests increased symptoms severity. Cut-oﬀ scores on the
BDI are not consistent across studies [47], but in this study
weclassiﬁedscoresatorabove11asindicativeofthepresence
of depression [48].
2.3.2. Hospital Anxiety and Depression (Zigmond and Snaith,
1983). The HADS-D is a 14-item self-screening paper
and pen questionnaire that assesses levels of anxiety and
depressive symptoms. It was initially designed for hospital
general medical outpatients but is now extensively used in
primary care and research. 7 items on the test are relevant to
depressive symptoms, and the other 7 to generalised anxiety.
Each item has 4 possible responses scored on a scale that
ranges from 0 to 3. For example, the item “I still enjoy the
things I used to enjoy,” has 4 possible responses: “deﬁnitely
as much (0), Not quite so much (1), Only a little (2), Hardly
at all (3).” This gives a possible maximum score of 21 for
either depression or anxiety. For purposes of this study we
only used the depression section of the scale and adopted a
cut-oﬀ score of 9 to distinguish between depressed and non-
depressed patients [40].
2.4. Executive Function Measure
2.4.1. The Tower of Hanoi Task. The ToH puzzle provided a
cognitive measure of executive function. Solving the puzzle
requires the use of forward planning and capacities related
toanticipatory,insightfulmeansendproblem-solvingstrate-
gies. A series of 10 ToH trials of varying levels of diﬃculty
were administered to each of the participants. The puzzle
consisted of a ﬂat wooden board with three vertical pegs
of equal height and diameter ﬁxed equidistantly from each
other and ﬁve wooden disks (disks A, B, C, D, and E).
On each of the 10 trials, the disks were placed in some
predetermined arrangement on the pegs (start state), and
participants had to rearrange the disks until they were all
staked in a descending order according to size on the middle
peg (the goal state; see Figure 1 below). Participant had to
followthreerules:(a)onlyonediskcouldbemovedatatime,
(b)anydisknotbeingmovedhadtoremainonapeg,and(c)
a larger disk could not be placed on top of a smaller disk. The
number of trials successfully completed on the task provided
the ToH score. For various reasons, scores on the ToH were
obtained for 25 patients.
3. Results
Data on all the apathy and depression scales was available
for 40 patients. Data for patients who did not have scores
on all the scales was excluded from analysis. Where data4 Current Gerontology and Geriatrics Research
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Figure 1: (Adopted from Goel and Grafman, 1995). Start states for 9
of the 10 ToH trials used in the study. The tenth trial (not included
inthediagram)hadastartstateinwhichdiscsAtoEwereallplaced
on the right peg, and it was administered after the 9th trial.
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Figure 2: Distribution of self- and informant-rated levels of apathy.
failedtomeettheassumptionsfortheuseofparametrictests,
nonparametric test equivalents were performed.
3.1. Apathy. Patient self ratings on the AES-S ranged from
20 to 57 (mean = 34.27, SD = 9.29). Informant ratings on
the AES-I ranged from 23 to 69 (Mean = 45.05, SD = 11.06).
Figure 2 shows the distribution of scores on the AES-S and
AES-I.
Based on the patients’ self evaluations on the AES-S, only
6(15%)metcriteriaforthepresenceofapathy,and34(85%)
patients self-evaluated themselves as not apathetic. On the
other hand informants rated 23 (57.5%) of the patients as
apathetic ontheAES-Iand17(42.5%) patients asnot having
apathy. Wilcoxon signed-rank tests performed on the data
to compare AES-S and AES-I scores showed that patients
evaluated their apathy levels signiﬁcantly lower (Mdn = 33.5)
than their informants (Mdn = 44.0), T = 18.8, P<0.001,
r =− .47. The eﬀect size (r =− .47) is large enough to
suggest that this ﬁnding is reliable.
Informant ratings on the NPI apathy subscale evaluated
24 (60%) patients as having signiﬁcant apathy symptoms,
and 16 (40%) as not apathetic. Informant-rated AES-I and
N P Ia p a t h ys c o r e sw e r ep o s i t i v e l yc o r r e l a t e d( rs = .71,
P<0.001). There were no signiﬁcant correlations between
patient-rated apathy scores on the AES-S and informant-
rated apathy scores on both the AES-I (rs = .27, ns) and
the NPI (rs = .26, ns; see Table 2).
3.2. Depression. Two (5%) patients met criteria for the
presence of depression on both the BDI and the HADS-D
and38(95%)hadnosigniﬁcantdepressivesymptoms.There
was a signiﬁcant positive correlation between depressive
symptoms scores on the HADS-D and the BDI (rs = .55,
P<0.001).
3.3. Apathy and Depression. Patients’ self-rated (AES-S)
apathyscorespositively correlatedwithdepressivesymptoms
scores on the HADS-D (rs = .48, P<0.01) and the BDI
(rs = .42, P<. 01).
There were no signiﬁcant correlations between
informant-rated apathy scores on the AES-I and NPI
and depressive symptoms scores on the HADS-D and BDI
(see Table 2).
3.4. Executive Function. Spearman’s rho tests showed a
signiﬁcantnegativecorrelationbetweenToHscoresandAES-
Ia p a t h ys c o r e s( rs = −.523, P<0.01). These results showed
that the higher the level of apathy in patients, the more they
were impaired on the task.
4. Discussion
Patient-rated apathy positively correlated with depressive
symptoms. No signiﬁcant relationship was found between
informant-rated apathy and depressive symptoms although
informant-rated apathy negatively correlated with executive
function performance on the ToH puzzle. Furthermore, our
patients underrated their apathy symptoms when compared
to how informants rated their apathy. The prevalence levels
for apathy obtained from patient rated scores were also
below the range reported in other studies on similar patients
using clinician or informant versions of the AES or diﬀerent
apathy instruments (e.g., [7, 8, 12]). The informant-rated
prevalence rate for apathy symptoms in our study (57.5%)
is similar to prevalence rates found in other studies (e.g.,
[29, 49–51]).Current Gerontology and Geriatrics Research 5
Table 2: Relationships between apathy and depression scores.
AES-S AES-I NPI HADS-D BDI
Correlation coeﬃcient 1.000 .266 .275 .480∗∗ .417∗∗
AES-S Sig. (2-tailed) · .093 .085 .001 .004
N 40 40 40 40 40
Correlation coeﬃcient 1.000 .707∗∗ .156 .058
AES-I Sig. (2-tailed) · .000 .330 .718
N 40 40 40 40
Correlation coeﬃcient 1.000 −.037 .078
NPI Sig. (2-tailed) · .819 .630
N 40 40 40
Correlation coeﬃcient 1.000 .554∗∗
HADS-D Sig. (2-tailed) · .000
N 40 40
Correlation coeﬃcient 1.000
BID Sig. (2-tailed) ·
N 40
∗∗. Correlation is signiﬁcant at the 0.01 level (2-tailed).
Patient-rated apathy scores have also shown positive
correlations with depressive symptoms in other studies. For
example, Veranese et al. [6] found a positive but weaker cor-
relationbetweenapathysymptomsanddepressivesymptoms
(Pearson index = 0.3; P<0.07) when patients rated their
own apathy symptoms. See also [36]. The evidence suggests
that patients tend to underrate their apathy symptoms [8].
Furthermore, informant ratings of apathy symptoms are
thought to provide a more reliable and valid measure of
apathy than patients’ self ratings [36]. Studies have also
shown that of the three AES versions, the patient-rated
version has the least favourable psychometric qualities [33].
There are suggestions that part of the apathy proﬁle
includes a dimension of diminished or lack of insight,
and a tendency to minimise or deny dysfunction [21,
37, 52]. Lack of insight is a possible reason why patient
ratings for apathy were lower than informant evaluations.
Currently, the exact nature of the relationship between lack
of insight and apathy symptoms is poorly understood. For
instance, a close association between apathy symptoms,
cognitive deﬁcits, and lack of insight has been reported in
numerous studies [5, 6, 53–55]. Relatedly, loss of insight
into one’s cognitive and functional problems (anosognosia)
is prevalent in most of the disorders in which apathy is
a common neuropsychiatric syndrome (see [37, 56–58]).
Furthermore, apathy and anosognosia are often associated
withfrontallobedysfunctionandarebothsensitivetofrontal
lesions (e.g., [37, 59, 60]). It is important to note that 90% of
the patients in our study had frontal lesions, and this could
have contributed to the pattern of our results.
It is not clear whether the validity and reliability issues
raised against patient-rated apathy would apply to patient-
rated depressive symptoms. The question is why, for exam-
ple, anosognosia or lack of insight would aﬀect patient self-
evaluations on apathy and not on depression. It is however
important to note that depressive symptoms scales used
in this study have enjoyed wide validation and reliability
testing and standardization and have demonstrated good
psychometric properties. This is not the case with the AES-
S. But more importantly, depression is largely a patient’s
subjective evaluation and experience of his or her situation.
Conceptually, a patient’s self evaluation on depression scales
tapes into this subjective experience of his condition. On
the other hand, in apathy, we are more interested in the
objectiveassessmentoflossoffunction.Apathyscalesshould
be able to give an objective assessment of the patient’s
motivational state, and the functional deﬁcits around inter-
personal relationships and the initiation and maintenance of
goal directed activity, whereas depression scores necessarily
target the patient’s subject experiences. Also, apathy is
seldom distressing to the patient, but often exerts signiﬁcant
caregiver burden, while depression distresses the patient
[61]. These factors may help explain why our patients
underestimated their apathy symptoms.
The low incidence of depression in our sample is in
line with results from other studies on similar patients [28].
It is however possible that in chronic samples, depressive
symptomsdominatetheclinicalpictureintheearlydaysafter
injury,andimprovesigniﬁcantlyaspatientsrecover,whileon
the other hand apathy symptoms become a more common
feature with time [62]. Since all our patients were at least
6 months after-injury, this could explain the low depressive
symptoms incidence, and the comparatively higher preva-
lenceofapathy.Theseresultshaveimportantimplicationsfor
clinical intervention and patient rehabilitation (see [63]).
While one can argue that patients may have a better
understanding of their own internally generated cognitive
processes, we enhanced the sensitivity of the informant
evaluations by administering them as a structured interview.
Administering the AES-I in this manner has been shown to
enhance its reliability and validity [4]. Higher informant-
rated apathy scores were also associated with executive func-
tion deﬁcits on the ToH, which further supports our view
that patient-evaluated apathy may have underestimated the6 Current Gerontology and Geriatrics Research
presence and levels of apathy. Understanding the variables
that mediate the relationship between apathy and depressive
symptomswillhelpoutlinethesyndronomicpositionofapa-
thy and inform diagnosis and intervention. In our study, the
positive correlation between depression and patient-rated
apathy is most likely a superﬁcial relationship which reﬂects
moreonotherpatient-relatedvariablessuchaslackofinsight
than anything else. More work is required in investigating
how patient insight relates to apathy symptoms. Our study
also emphasises the need for caution in interpreting patients’
self-evaluations on apathy.
5. Conclusion
Thisstudydemonstratesthatthechoiceofapathyassessment
tools can produce diﬀerential results on the relationship
between apathy and depression. It also raises questions
on the clinical utility of patient ratings when assessing
apathy. These results oﬀer a possible explanation to some of
the mixed results that studies on the relationship between
apathy and depression have produced. As this research
demonstrates, one of the factors involved may be something
to do with who rates the apathy symptoms. Future studies
may also include independent measures of lack of insight in
order to control for its eﬀects on the relationship.
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